Zomedica Corp. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Zomedica Corp. (ZOMDF) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $4.45 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.45M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.88M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.25M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.07M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $4.45M 10-K · filed 2026-03-16 |
| 2024-12-31 | $3.88M 10-K · filed 2026-03-16 |
| 2023-12-31 | $3.25M 10-K · filed 2025-03-13 |
| 2022-12-31 | $3.07M 10-K · filed 2024-04-01 |
| 2021-12-31 | $3.43M 10-K · filed 2022-03-01 |
| 2020-12-31 | $1.15M 10-K · filed 2022-03-01 |
| 2019-12-31 | $301.18K 10-K · filed 2021-02-26 |
| 2018-12-31 | $171.59K 10-K · filed 2020-02-26 |
| 2017-12-31 | $89.97K 10-K/A · filed 2019-03-14 |
| 2016-12-31 | $23.12K 10-K · filed 2018-02-28 |